Vomaris seeks accelerated approval for masks shown to kill viruses

Biotechnology company Vomaris plans to expedite the approval of its bioelectric V.Dox system after research has indicated that viruses are killed upon exposure to the technology, the Daily Independent reports.

Advertisement

Three things to know:

1. The technology is designed for wound dressings, but Vomaris has been applying it to masks, which has been shown to reduce the risk of bacterial spread.

2. V.Dox is a dot matrix pattern of embedded microcell batteries that creates electricity when it detects moisture.

3. Jimmy Chow, MD, an orthopedic surgeon and founder of the Orthopedic Institute in Phoenix, has recorded a 0.02 percent patient infection rate, while using Vomaris’ wound dressing technology in his practice.

“It’s been clearly shown to destroy infection-causing agents that are classically hard to kill,” Dr. Chow said. “And since viruses are electrically charged, it follows that V.Dox technology would also be effective at neutralizing viruses.”

More articles on devices:
COVID-19 eases telemedicine’s shackles, expansion looks bright for orthopedics
Life Spine, Northern Light Health & more: 5 spine, orthopedic partnerships in the past month
Spinal robotics market to hit $320M by 2026: 3 updates

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.